GABRIEL PEREZ LASALA
Pilots at Tradition Dr, Covington, LA
License number
Louisiana A5279854
Issued Date
Nov 2015
Expiration Date
Nov 2017
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
803 Tradition Dr, Covington, LA 70433
Professional information
Dr. Gabriel P Lasala, Bogalusa LA - MD (Doctor of Medicine)
Specialties:
Cardiology, Interventional Cardiology
Address:
Tchefuncte Cardiovascular Associates
335 Austin St, Bogalusa 70427
(985) 898-1276 (Phone)
Tchefuncte Cardiovascular Associates
809 Boat Ramp Rd, Franklinton 70438
(985) 898-1276 (Phone), (985) 839-9842 (Fax)
Tchefuncte Cardiovascular associates
1006 S Harrison St, Covington 70433
(985) 871-4044 (Phone), (985) 893-8919 (Fax)
Tchefuncte Cardiovascular Associates
101 Fairway Dr, Covington 70433
(985) 898-1276 (Phone), (985) 871-1548 (Fax)
Tchefuncte Cardiovascular Associates
105 Medical Center Dr, Slidell 70461
(985) 641-9497 (Phone)
335 Austin St, Bogalusa 70427
(985) 898-1276 (Phone)
Tchefuncte Cardiovascular Associates
809 Boat Ramp Rd, Franklinton 70438
(985) 898-1276 (Phone), (985) 839-9842 (Fax)
Tchefuncte Cardiovascular associates
1006 S Harrison St, Covington 70433
(985) 871-4044 (Phone), (985) 893-8919 (Fax)
Tchefuncte Cardiovascular Associates
101 Fairway Dr, Covington 70433
(985) 898-1276 (Phone), (985) 871-1548 (Fax)
Tchefuncte Cardiovascular Associates
105 Medical Center Dr, Slidell 70461
(985) 641-9497 (Phone)
Procedures:
Ambulatory Holter Monitoring, Cardiac (Heart) Catheterization, Cardiac Catheterization & Angioplasty Stenting, Ct Scan (Computed Tomography), Diagnostic Heart Catheterization, Echocardiogram, Ekg (Electrocardiogram, Ecg), Exercise & Pharmacological Ecg Stress Testing, Implant Defibrillators, Interventional Catheterization, Laser Vein Treatment & Removal, Pacemakers, Peripheral Angioplasty, Rotational Atherectomy, Vascular Non-Invasive Studies, Vascular Ultrasound Studies, Venography
Awards:
Stem Cell Success, September, Effect of torcetrapib on Progression of Coronary Atherosclerosis, March 23,
Languages:
English, Spanish
Hospitals:
Tchefuncte Cardiovascular Associates
335 Austin St, Bogalusa 70427
Tchefuncte Cardiovascular associates
1006 S Harrison St, Covington 70433
Tchefuncte Cardiovascular Associates
101 Fairway Dr, Covington 70433
Tchefuncte Cardiovascular Associates
809 Boat Ramp Rd, Franklinton 70438
Tchefuncte Cardiovascular Associates
105 Medical Center Dr, Slidell 70461
St. Tammany Parish Hospital
1202 South Tyler St, Covington 70433
335 Austin St, Bogalusa 70427
Tchefuncte Cardiovascular associates
1006 S Harrison St, Covington 70433
Tchefuncte Cardiovascular Associates
101 Fairway Dr, Covington 70433
Tchefuncte Cardiovascular Associates
809 Boat Ramp Rd, Franklinton 70438
Tchefuncte Cardiovascular Associates
105 Medical Center Dr, Slidell 70461
St. Tammany Parish Hospital
1202 South Tyler St, Covington 70433
Education:
Medical School
Universidad Nacional De Cordoba, Facultad De Ciencias Medicas
Graduated: 1980
University Of Mississippi
University Of Mississippi Medical Center/Univ Hosps & Clinic
University Of Mississippi Medical Center
Universidad Nacional De Cordoba, Facultad De Ciencias Medicas
Graduated: 1980
University Of Mississippi
University Of Mississippi Medical Center/Univ Hosps & Clinic
University Of Mississippi Medical Center
Background:
Sanctions: 2 time(s)
Gabriel P Lasala, Covington LA
Specialties:
Cardiologist
Address:
101 Judge Tanner Blvd, Covington, LA 70433
Intracoronary, Intracardiac, Or Intravenous Infusion Of A Mixture Of Autologous Bone Marrow Derived Mononuclear Cells And Autologous Bone Marrow Derived Mesenchymal Stem Cells For Utilization And Rescue Of Infarcted Myocardium
US Patent:
2009003, Feb 5, 2009
Filed:
Oct 6, 2008
Appl. No.:
12/287086
Inventors:
Jose J. Minguell - Santiago, CL
Gabriel Perez Lasala - Covington LA, US
Gabriel Perez Lasala - Covington LA, US
International Classification:
A61K 35/28, A61P 9/00
US Classification:
424 937
Abstract:
The present invention is a method for improving cardiac function and myocardial regeneration in living subjects after the occurrence of myocardial infarction. The method is a combination stem cell therapy involving a mixture of bone marrow-derived mesenchymal stem cells and bone marrow derived mononuclear cells surgically implanted by using either a direct or catheter-mediated injection into damaged myocardium. Studies have shown that the implant improves heart function and myocardial regeneration and echocardiographic measurements.
Intracoronary Injection Of A Mixture Of Autologous Bone Marrow Derived Mononuclear Cells And Autologous Bone Marrow Derived Mesenchymal Stem Cells For Utilization And Rescue Of Infarcted Myocardium
US Patent:
2008003, Feb 14, 2008
Filed:
Aug 8, 2006
Appl. No.:
11/500317
Inventors:
Jose J. Minguell - Santiago, CL
Gabriel Perez Lasala - Covington LA, US
Gabriel Perez Lasala - Covington LA, US
International Classification:
A61K 35/14
US Classification:
424 937
Abstract:
The present invention is a method for improving cardiac function and myocardial regeneration in living subjects after the occurrence of myocardial infarction. The method is a combination stem cell therapy involving a mixture of bone marrow-derived mesenchymal stem cells and bone marrow derived mononuclear cells surgically implanted by using either a direct or catheter-mediated injection into damaged myocardium. Studies have shown that the implant improves heart function and myocardial regeneration as assessed by MRI, SPECT and echocardiographic measurements.
Infusion Of A Mixture Of Autologous Bone Marrow-Derived Mononuclear Cells And Autologous Or Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells For Treating Myocardial And/Or Cardiovascular Disorders
US Patent:
2011004, Feb 24, 2011
Filed:
Nov 3, 2010
Appl. No.:
12/939041
Inventors:
Jose J. Minguell - Covington LA, US
Gabriel P. Lasala - Covington LA, US
Gabriel P. Lasala - Covington LA, US
International Classification:
A61K 35/12, A61K 35/32
US Classification:
424 933
Abstract:
The present invention is a method for improving cardiac and/or cardiovascular functions in living subjects after the occurrence of a myocardial and/or cardiovascular disorder, involving tissue damage and/or an ischemic event. The method is a combination stem cell therapy involving a mixture of bone marrow-derived mesenchymal stem cells and bone marrow-derived mononuclear cells surgically implanted by using either a direct or catheter-mediated injection into damaged tissue. Studies have shown that the implant improves blood perfusion in an ischemic tissue and thus contributes to the recovery of cardiac and/or cardiovascular function as assessed by methods of choice, including magnetic resonance imaging (“MRI”), echocardiography, angiography and 99mTc-TF perfusion scintigraphy.
Intracoronary, Intracardia, Or Intravenous Infusion Of A Mixture Of Autologous Bone Marrow Derived Mononuclear Cells And Autologous Bone Marrow Derived Mesenchymal Stem Cells For Utilization And Rescue Of Infarcted Myocardium
US Patent:
2009028, Nov 19, 2009
Filed:
Jun 15, 2009
Appl. No.:
12/456318
Inventors:
Jose J. Minguell - Sanliago, CL
Gabriel Parenz Lasala - Covington LA, US
Gabriel Parenz Lasala - Covington LA, US
International Classification:
A61K 35/28, A61P 9/00
US Classification:
424 937
Abstract:
The present invention is a method for improving cardiac function and myocardial regeneration in living subjects after the occurrence of myocardial infarction. The method is a combination stem cell therapy involving a mixture of bone marrow-derived mesenchymal stem cells and bone marrow derived mononuclear cells surgically implanted by using either a direct or catheter-mediated injection into damaged myocardium. Studies have shown that the implant improves heart function and myocardial regeneration as assessed by MRI, SPECT and echocardiographic measurements.